Cargando…

The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report

RATIONALE: Limbic encephalitis is one of the most common paraneoplastic neurological disorders (PND). The role of brain Fluorine-18-fluorodeoxyglucose position emission tomography/computed tomography (CT) in paraneoplastic limbic encephalitis (PLE) and of the whole body 18F-FDG PET/CT in this settin...

Descripción completa

Detalles Bibliográficos
Autores principales: Castagnoli, Helga, Manni, Carlo, Marchesani, Francesca, Rossi, Gloria, Fattori, Sara, Capoccetti, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736484/
https://www.ncbi.nlm.nih.gov/pubmed/31464894
http://dx.doi.org/10.1097/MD.0000000000016593
_version_ 1783450525835984896
author Castagnoli, Helga
Manni, Carlo
Marchesani, Francesca
Rossi, Gloria
Fattori, Sara
Capoccetti, Francesca
author_facet Castagnoli, Helga
Manni, Carlo
Marchesani, Francesca
Rossi, Gloria
Fattori, Sara
Capoccetti, Francesca
author_sort Castagnoli, Helga
collection PubMed
description RATIONALE: Limbic encephalitis is one of the most common paraneoplastic neurological disorders (PND). The role of brain Fluorine-18-fluorodeoxyglucose position emission tomography/computed tomography (CT) in paraneoplastic limbic encephalitis (PLE) and of the whole body 18F-FDG PET/CT in this setting, remains still not well defined. PATIENT CONCERNS: We report a case of a patient with chronic inflammatory rheumatism, psoriasis and Hashimoto thyroiditis and subsequent appearance of static and dynamic ataxia and episodic memory deficit who was diagnosed as PLE combined with small cell lung cancer (SCLC). DIAGNOSES: The diagnosis of SCLC was made with EBUS-TBNA of a mediastinal lymph node. INTERVENTIONS: Whole-body 18F-FDG PET/CT was performed for the initial staging of SCLC, in the planning of radiotherapy treatment, to evaluate therapeutic response and in the follow-up. A dedicated brain scan was included to the same PET session. Whole-body contrast enhanced computed tomography (CT) and contrast enhanced whole-brain MRI were also performed. OUTCOMES: She was administered neoadjuvant chemioterapy with Cisplatin and Etoposide with concomitant radiotherapy treatment. Whole body 18F-FDG PET/CT showed a complete metabolic response already after 3 cycles of chemioterapy. Brain functional study showed a metabolic pattern characterized by the migration of hypermetabolism in the bilateral hippocampal areas during the therapeutic treatment, which correlated with the persistence of clinical symptoms. LESSONS: In the era of personalized medicine and targeted therapy, this case highlights the importance of the 18F-FDG PET/CT study as an accurate tool to identify PLE and to guide the diagnostic work-up of the underlying tumor. Considering that most of these are 18F-FDG avid tumors and that the 18F-FDG PET/CT scan is often added to the diagnostic work-up when screening patients for malignancy, this functional imaging can play a decisive role.
format Online
Article
Text
id pubmed-6736484
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67364842019-10-02 The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report Castagnoli, Helga Manni, Carlo Marchesani, Francesca Rossi, Gloria Fattori, Sara Capoccetti, Francesca Medicine (Baltimore) 6800 RATIONALE: Limbic encephalitis is one of the most common paraneoplastic neurological disorders (PND). The role of brain Fluorine-18-fluorodeoxyglucose position emission tomography/computed tomography (CT) in paraneoplastic limbic encephalitis (PLE) and of the whole body 18F-FDG PET/CT in this setting, remains still not well defined. PATIENT CONCERNS: We report a case of a patient with chronic inflammatory rheumatism, psoriasis and Hashimoto thyroiditis and subsequent appearance of static and dynamic ataxia and episodic memory deficit who was diagnosed as PLE combined with small cell lung cancer (SCLC). DIAGNOSES: The diagnosis of SCLC was made with EBUS-TBNA of a mediastinal lymph node. INTERVENTIONS: Whole-body 18F-FDG PET/CT was performed for the initial staging of SCLC, in the planning of radiotherapy treatment, to evaluate therapeutic response and in the follow-up. A dedicated brain scan was included to the same PET session. Whole-body contrast enhanced computed tomography (CT) and contrast enhanced whole-brain MRI were also performed. OUTCOMES: She was administered neoadjuvant chemioterapy with Cisplatin and Etoposide with concomitant radiotherapy treatment. Whole body 18F-FDG PET/CT showed a complete metabolic response already after 3 cycles of chemioterapy. Brain functional study showed a metabolic pattern characterized by the migration of hypermetabolism in the bilateral hippocampal areas during the therapeutic treatment, which correlated with the persistence of clinical symptoms. LESSONS: In the era of personalized medicine and targeted therapy, this case highlights the importance of the 18F-FDG PET/CT study as an accurate tool to identify PLE and to guide the diagnostic work-up of the underlying tumor. Considering that most of these are 18F-FDG avid tumors and that the 18F-FDG PET/CT scan is often added to the diagnostic work-up when screening patients for malignancy, this functional imaging can play a decisive role. Wolters Kluwer Health 2019-08-30 /pmc/articles/PMC6736484/ /pubmed/31464894 http://dx.doi.org/10.1097/MD.0000000000016593 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 6800
Castagnoli, Helga
Manni, Carlo
Marchesani, Francesca
Rossi, Gloria
Fattori, Sara
Capoccetti, Francesca
The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report
title The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report
title_full The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report
title_fullStr The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report
title_full_unstemmed The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report
title_short The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report
title_sort role of 18f-fdg pet/ct in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: a case report
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736484/
https://www.ncbi.nlm.nih.gov/pubmed/31464894
http://dx.doi.org/10.1097/MD.0000000000016593
work_keys_str_mv AT castagnolihelga theroleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT mannicarlo theroleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT marchesanifrancesca theroleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT rossigloria theroleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT fattorisara theroleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT capoccettifrancesca theroleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT castagnolihelga roleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT mannicarlo roleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT marchesanifrancesca roleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT rossigloria roleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT fattorisara roleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport
AT capoccettifrancesca roleof18ffdgpetctinmanagementofparaneoplasticlimbicencephalitiscombinedwithsmallcelllungcanceracasereport